M yopia is the most common eye disorder and is found in approximately 25% of the adult population in the United States. [1] [2] [3] [4] [5] High-grade myopia of 6.00 D or greater severity, also termed pathologic myopia, is a major cause of legal blindness in many developed countries, with a prevalence of 1.7% to 2.1% in the general population of the United States. 6 -9 Highgrade myopia is especially common in Asia. 10 -12 Comparative prevalence rates from different countries show considerable variability, but confirm that myopia affects a significant proportion of the population in many countries. 2,8,10 -13 Determining the role of genetic factors in the development of nonsyndromic common myopia has been hampered by the high prevalence, genetic heterogeneity, and clinical spectrum of this condition. Despite the impediments inherent in mapping genes for a complex common disorder such as myopia, considerable progress has been made in the past few years. An X-linked recessive form of myopia has been mapped and was designated the first myopia locus, MYP1.
14 Reanalysis of this Danish pedigree (MYP1) and another X-linked pedigree of Danish descent suggests that this disease locus involves a cone dysfunction and not simple myopia. 15 We have also studied several medium to large multigenerational families with AD high-grade myopia and found significant linkage at 18p11.31 (MYP2), 12q23.1-q24 (MYP3), and 17q21-q23 (MYP5). 16 -18 Suggestive linkage for AD high-grade myopia was found on chromosome 7 at q36 (MYP4). 19 Two recent studies have determined loci for common myopia: one in dizygotic twins with linkage to chromosome 11 at p13 in the PAX6 gene region 20 and another in Ashkenazi Jews with linkage to chromosome 22 at q12 (MYP6). 21 Herein, we provide further evidence for the genetic heterogeneity of high-grade myopia by excluding myopia loci at 18p, 12q, 17q, 7q, 11p, and 22q. We report significant linkage to a novel AD locus on the long arm of chromosome 2 in a large, multigenerational family. The proband was examined at 8 weeks of age and was found to have a highly myopic refractive error. He was provided spectacle correction at 10 months of age and had a spherical refractive error of approximately Ϫ17.00 D. In this family, a variable spectrum of spherical myopic refractive error was observed in 14 individuals, with a range of Ϫ7.25 to Ϫ27.00 D. Two positional candidate genes, S-antigen (SAG) and diacylglycerol kinase delta (DGKD), were screened for sequence variants in this family.
METHODS

Subject Data Collection
A large U.S. family of northern European extraction (Pedigree MYO-056) with 31 consenting members (14 affected) participated in the study. The study was approved by the Institutional Review Board of The Children's Hospital of Philadelphia and adhered to the tenets of the Declaration of Helsinki. This family was chosen based on the presence of numerous male and female family members and successful multiple generations with high-grade myopia, suggesting an AD mode of inheritance. Individuals with a spherical refractive error ՅϪ6.00 D and a history of myopia onset before 12 years of age were considered affected. No participants had known ocular disease or insult that could predispose to myopia or any known genetic syndrome associated with high-grade myopia. A comprehensive ophthalmic examination and blood collection was performed by one of the authors (TLY), as previously described. 16 In most instances, participants declined kera- The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Table 1 .
Screening for Known Candidate and Syndromic Loci
Initially, 11 candidate loci were screened by using flanking and intragenic microsatellite markers specific for the six known myopia loci mentioned earlier, as well as the five known myopic genetic syndromes of Stickler syndrome types I, II, and III; Marfan syndrome; and juvenile glaucoma, as described previously.
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Genotyping
Genome screening was performed on pedigree MYO-056, with 382 microsatellite markers from a commercial set (Prism Linkage Mapping Set-MD10; Applied Biosystems, Inc. Multiplexed PCR products (three or four combined amplicons, depending on the size range for adequate amplicon spacing) were electrophoresed on an automated DNA sequencer (Prism 377; ABI). The gel-file output was checked for correct lane tracking, and the allele size was determined on computer (GeneScan analysis software; ABI), and genotyping software (Genotyper; ABI) was used for automated allele calling and manual verification. After the initial genome screening, markers from a linkage mapping set (Linkage Mapping Set-HD5; ABI) with an average intermarker distance of 5 cM and additional custommade markers with high heterozygosity were selected from publicly available genetic maps 22, 23 were added in all regions with positive lod scores. The additional marker amplicons were run on a newer auto-FIGURE 2. Multipoint lod score data on the MYO-056 family for chromosome 2 at region q37 with marker order in gray boxes on the x-axis. Lod scores were plotted against the marker distance in centimorgans. 
Linkage Analysis
Mendelian error checking was performed with PedManager, ver. 0.9. Mega2, ver. 3.0, 24 was used to create the files needed for linkage analysis by using SimWalk2, ver. 2.89. [25] [26] [27] SimWalk2 was used for multipoint linkage analysis based on an AD model with 90% penetrance, 0.1% phenocopy rate, and a myopia gene frequency of 0.01. Two-point linkage analysis was performed with the MLINK program from the FASTLINK 4.0 software package 28 -30 for the region of interest on chromosome 2 at q37. Marker allele frequencies were estimated based on our pedigree data. Sex-average genetic marker maps were used from the internet database of the Marshfield Center for Medical Genetics. (Internet locations of databases used in the study are provided in Appendix A).
Positional Candidate Gene Mutation Screening
SAG contains 14 exons encoding a protein of 406 residues.
31,32 DGKD contains 30 exons and two transcript variants encoding two proteins of 1170 (DGKD1) and 1214 (DGKD2) residues. 33 We designed and optimized 15 novel sets of forward and reverse primer pairs for SAG and 31 for DGKD, which extended 50 to 200 bp beyond each intronexon boundary (Appendix B). For each amplimer, PCR was performed on 150 ng of participant genomic DNA using Taq polymerase (AmpliTaq Gold; Roche Molecular Systems, Inc., Branchburg, NJ) at 55°C annealing temperature. Amplified products were separated by agarose gel electrophoresis and visualized by staining with ethidium bromide. Five highly myopic affected family members were screened, and four control subjects with either plano or hyperopic refractive error were obtained from family marry-ins, nonmyopic family members, and unrelated subjects. External control subjects were self-defined as white and were from the United States.
Denaturing High Performance Liquid Chromatography
A DNA fragment analysis system (Wave) and associated software (Navigator; Transgenomic, Inc., Omaha, NE) were used for denaturing high performance liquid chromatography (DHPLC). A mixture of 15 L of each amplicon from a subject's DNA was heated for 5 minutes at 95°C and then cooled to room temperature. An aliquot (5 L) of the DNA mixtures was directly injected into a separation column. Each fragment was analyzed by using three partially denaturing temperatures, which were based on fragment-melting profiles. Sample amplicons exhibiting a heteroduplex pattern (with a shorter retention time than that of the normal control) were sequenced to confirm putative sequence variations. PCR products were purified (ExoSAP-IT; USB Corp., Cleveland, OH) and sequenced with dye terminator chemistry (BigDye Terminator, ver. 3.1 on a 3730 DNA Analyzer; ABI).
RESULTS
A large, multigenerational, U.S. family of northern European extraction with AD high-grade myopia (pedigree MYO-056) was identified and characterized ( Fig. 1) . DNA was available from 31 family members (14 affected The initial 10-cM genome screen did not show suggestive evidence of linkage, as no lod score above 2.00 was obtained. However, three chromosomal regions, on 2q, 3p, and 10p had lod scores Ͼ1.00. In each region, additional polymorphic markers were genotyped and analyzed by linkage analysis. The new markers for 3q and 10p gave lower lod scores, and multipoint analysis confirmed the exclusion of these regions. In contrast, the lod scores for an interval on 2q increased, showing significant evidence of linkage between markers D2S172 and D2S336 (Fig. 2) . Two-point analysis identified significant linkage at markers D2S2344 and D2S2348 ( Table 2 ). The maximum multipoint lod score was 4.75 for marker D2S2344 (Fig. 2) . Based on the 1-unit support intervals, the critical region for myopia susceptibility gene in this family spans approximately 9.1 cM (from 238.7 to 247.8 cM) on the chromosome 2 genetic map at 2q37.1 (Fig. 2) .
Haplotype analysis revealed recombination events that could help narrow the critical region containing the gene to 2.22 cM, between markers D2S1279 and D2S2205 at 2q37.1 (Fig. 3) . Biologically relevant candidate genes found between markers D2S1279 and D2S2205 at 2q37.1 were S-antigen (also known as S-arrestin; SAG) and diacylglycerol kinase delta (DGKD; 130 kDa). Mutation screening of SAG resulted in seven polymorphisms (three missense and four intronic), but none of these segregated with the affection status. DGKD mutation screening revealed six intronic polymorphisms in this family, again without affection status cosegregation (Table 3) . Five polymorphisms were novel and have been submitted to the National Center for Biotechnology Information (NCBI) dbSNP database. Eight polymorphisms corresponded with previously reported single nucleotide polymorphisms (SNPs) in public databases. A pattern change was observed in exon 9 for all the samples within the SAG gene, apparently due to a poly-A stretch. Whether the pattern change was due to a novel polymorphism in the number of A's in this region (position 183522) could not be confirmed, because of difficulty in sequencing through that homopolymer stretch.
DISCUSSION
In this study, we have identified a novel locus for AD highgrade myopia and provide additional evidence for genetic heterogeneity of this phenotype. Linkage to early-onset disorders associated with high-grade myopia (Marfan syndrome, juvenile glaucoma, and the Stickler syndromes) was excluded, to ensure that the family did not exhibit a mild phenotypic expression of these conditions limited to the ocular findings. Linkage to known candidate loci for AD myopia was also excluded.
After genome-wide screening and fine mapping were performed, the only region that showed evidence of linkage to the myopia trait in this family was on chromosome 2 at q37.1, with a maximum multipoint lod score of 4.75 at marker D2S2344. (Fig. 1) . Although the data for each individual are consistent with the rules of Mendelian inheritance, the occurrence of a double recombinant in this small interval is unlikely. The order of the maps was checked in all the public databases (Généthon and Golden Path, University of California Santa Cruz [UCSC], Genome Bioinformatics, University of California Santa Cruz, CA.) including the sequence of the human genome from NCBI. We also repeated the genotyping analysis for the two intervening markers (D2S1279 and D2S206) twice and obtained the same results. A centromeric recombination event was noted between markers D2S1279 and D2S2348 in the third generation. Unaffected individual 35 had the same haplotype for markers proximal to D2S2348 as did his affected siblings 34 and 36. This finding excludes this region from containing the disease gene, unless we assume that individual 35 is in fact a nonpenetrant carrier. We consider this unlikely, because individual 35 has no refractive error compared with his affected siblings ( Table 1 ). The allele shared by all affected individuals for the highest lod score marker D2S2348 is multiallelic (89% heterozygosity) and has 10 alleles in this family. Thus, it is highly unlikely that the affected allele is a common allele. This refines the critical region containing the gene to 2.22 cM, between markers D2S1279 and D2S2205 on chromosome 2 at q37.1 (Fig. 3) .
A search for genes physically mapped between markers D2S1279 and D2S2205 revealed eight regulatory or structural genes, four hypothetical genes, and one cDNA clone (UCSC database). Among these are potassium channel, inwardly rectifying, subfamily j, member 13 (KCNJ13); neuronal guanine nucleotide exchange factor (NGEF); neuraminidase 2 (NEU2); inositol polyphosphate-5-phosphatase (INPP5D; 145 kDa); Santigen (also known as S-arrestin; SAG); diacylglycerol kinase, delta (DGKD; 130 kDa); and ubiquitin-specific proteinase 40 (USP40). Of these, SAG and DGKD are biologically relevant candidate genes for this newly identified myopia locus, as both of these genes are expressed in human retina. [31] [32] [33] SAG is a major soluble photoreceptor protein that is involved in desensitization of the photoactivated transduction cascade. 32 It is expressed in the retina and pineal gland and inhibits coupling of rhodopsin to transducin in vitro. 31, 32 Mutations in this gene have been associated with Oguchi disease, 34 a rare autosomal recessive form of night blindness. DGKD encodes a cytoplasmic enzyme that phosphorylates diacylglycerol to produce phosphatidic acid. 33 Diacylglycerol kinase (DGK) has many isozymes, all containing characteristic zinc finger structures, and plays an important role in cellular signal transduction. 35 DGK genes cause retinal degeneration in Drosophila and are considered candidate genes for mammalian eye diseases. 35 An isozyme of the DGK gene (DGKG) was predominantly expressed in human retina. 36 Alternative splicing of DGKD results in two transcript variants encoding different isoforms (DGK␦1 and DGK␦2). Expression studies revealed limited expression of DGK␦1, but DGK␦2 was ubiquitously expressed in all normal human tissues. 37 SAG and DGKD both are expressed in the retina and may influence the growth of the eye. Direct sequence screening of the coding regions of both genes did not reveal any myopia-implicated mutations.
Novel SNPs observed with both genes were submitted to the public SNP database (see Appendix A). Observed frequencies were submitted for known SNPs. Currently, we are investigating other genes in this region.
In summary, we have mapped a novel chromosomal locus for high-grade myopia. Mutational characterization of the remaining genes in this locus for high-grade myopia will provide additional insight into the molecular mechanisms underlying this most common form of visual impairment and into the regulation of eye growth. We also continue our work to identify other possible loci for myopia.
